Dovitinib multi target TKI
Description Results NMA

CHIR-258 - CHIR258 - CHIR 258 - dovitinib - TKI-258 - TKI258 - TKI 258      

  • Group by...

pdf
pathology Demonstrated benefit and harm k      
renal-cell carcinoma (advanced)

versus

No demonstrated result for efficacy

1 trialmeta-analysis



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons